Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|August 13, 2009
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphomaStephen D Smith, Brian J Bolwell, Anjali S Advani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation RecipientsReema R Mathanda, Betty K Hamilton, Lisa Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemiaRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Blood Advances|January 4, 2018
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 studyDaniel J DeAngelo, Wendy Stock, Anthony S Stein, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
American Journal of Hematology|January 10, 2019
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicinElias Jabbour, Anjali S Advani, Matthias Stelljes, et al.
Blood Cancer Journal|January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Blood Neoplasia|October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United StatesSudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22Hagop M Kantarjian, Wendy Stock, Ryan D Cassaday, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Pageof 11